Standard treatment for lower-risk MDS - Where do we stand?

EHA Library, Eva Hellström- Lindberg, 136672

Clinical implications of gene mutations in MDS

EHA Library, Rafael Bejar, 136671

Progress in treatment of ALL in adults

EHA Library, Nicola GÖKBUGET, 136670

New technologies for MRD in ALL- challenges and opportunities

EHA Library, Jaques J. M. van Dongen, 136669

The role of non-coding DNA in the pathogenesis of T-ALL

EHA Library, Marc R. Mansour, 136668

JAK inhibitors in MF and PV

EHA Library, Haifa Kathrin Al-Ali, 136667

Mutations and their clinical implications

EHA Library, Paola Guglielmelli, 136666

Role of CALR and its deregulation in MPN

EHA Library, Thorsten Klampfl, 136665

Who should be transplanted in the molecular era?

EHA Library, Richard Schlenk, 136664

Targeting mutant IDH

EHA Library, Eytan Stein, 136663

Dissecting genetic and phenotypic heterogeneity to deliver personalized predictions in AML patients

EHA Library, Elli Papaemmanuil, 136662

Management of MCL in the era of targeted drugs

EHA Library, Tadeusz Robak, 136661

Risk-stratification therapy in MCL

EHA Library, Emmanuelle Zucca, 136660

Sickle cell disease and red cell volume

EHA Library, John Gibson, 137100

Predicting disease behavior in MM - Molecular risk factors and the road to stratified medicine

EHA Library, Martin Kaiser, 137095

Molecular pathogenesis of MCL

EHA Library, German Ott, 136659

BENEFIT OF RITUXIMAB AS SECOND LINE TREATMENT CHOICE FOR AUTOIMMUNE HEMOLYTIC ANEMIA IN CHILDREN : A PROSPECTIVE FRENCH COHORT.

EHA Library, Stéphane Ducassou, 135331

PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: KEYNOTE-013

EHA Library, Pier Luigi Zinzani, 135291

BET INHIBITOR AS A NOVEL THERAPEUTIC APPROACH FOR THE TREATMENT OF MLL-REARRANGED INFANT ACUTE LEUKEMIA

EHA Library, Michela Bardini, 135296

SUCCESSFUL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TEN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA USING AN INTENSIVE IMMUNOMYELOSUPPRESSIVE CONDITIONING REGIMEN: THE RESULTS OF A SINGLE INSTITUTE

EHA Library, Yoko Mizoguchi, 135326

LOW-DOSE CHEMOTHERAPY FOLLOWED BY ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS INDUCES REMISSIONS IN PATIENTS WITH ADVANCED LYMPHOMA

EHA Library, Stephanie Goff, 135286

SUPER-ENHANCER ANALYSIS DEFINES NOVEL AML AND MDS SUB-TYPES SENSITIVE TO SY-1425, A POTENT AND SELECTIVE RARA AGONIST

EHA Library, Michael McKeown, 135301

QUANTIFICATION OF IGG ANTI-ADAMTS13 ANTIBODY LEVEL CAN PREDICT THE LIKELIHOOD OF MORTALITY IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Ferras Alwan, 135321

RESULTS FROM ONGOING PHASE 2 REGISTRATION STUDY OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

EHA Library, Naveen Pemmaraju, 135306

CARDIAC UPTAKE IN AL AMYLOIDOSIS OF 99MTC-DPD AS A NOVEL MARKER OF POOR PROGNOSIS IN SYSTEMIC AL AMYLOIDOSIS

EHA Library, Jiexin ZHENG, 135311

DONOR AND RECIPIENT TOLL-LIKE RECEPTOR 1 VARIATIONS COMPARABLY PREDICT TRANSPLANT-RELATED MORTALITY AFTER UNRELATED BONE MARROW TRANSPLANTATION.

EHA Library, Kaori Uchino, 135316

COMPARISON OF OUTCOMES AFTER SINGLE OR DOUBLE UNIT UCBT FOLLOWING RIC IN ADULTS WITH ACUTE LEUKEMIA: A REPORT FROM EUROCORD, THE ALWP & THE CORD BLOOD COMMITTEE OF THE CTIWP OF THE EBMT

EHA Library, Frederic Baron, 135315

DELETION OF CDKN2C DRIVES THE PROGNOSTIC IMPACT OF DELETION 1P IN MULTIPLE MYELOMA

EHA Library, Martin Kaiser, 135310

LONG-TERM RISK OF CARDIOVASCULAR EVENTS FOLLOWING SPLENECTOMY ? A DANISH POPULATION-BASED COHORT STUDY

EHA Library, Marianne Rørholt, 135320

RESPONSE-ADAPTED SEQUENTIAL AZACITIDINE AND INDUCTION CHEMOTHERAPY IN PATIENTS > 60 YEARS OLD WITH NEWLY DIAGNOSED AML ELIGIBLE FOR CHEMOTHERAPY (RAS-AZIC): INTERIM ANALYSIS OF THE DRKS00004519 STUDY

EHA Library, Nadja Jaekel, 135305

GPR56 CONTRIBUTES TO THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA IN MICE

EHA Library, Nicole Kirsten, 135300

UPDATED RESULTS FROM ZUMA-1: A PHASE 1-2 MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF KTE-C19 (ANTI-CD19 CAR T CELLS) IN REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Tanya Siddiqi, 135285

HAPLO-IDENTICAL TRANSPLANTATION FOR ACQUIRED SEVERE APLASTIC ANEMIA IN A MULTI-CENTER PROSPECTIVE STUDY

EHA Library, Zhengli Xu, 135325

ALLOGENEIC STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A MULTICENTER EXPERIENCE

EHA Library, Moreno Benedetto Festuccia, 135290

LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH BETA-THALASSEMIA

EHA Library, Antonio Piga, 135330

ACTIVATED JAK-STAT SIGNALING COOPERATES WITH HOXA9 AND DRIVES LEUKEMIA DEVELOPMENT

EHA Library, Charles de Bock, 135295

HIGH EXPRESSION OF THE STEM CELL MARKER GPR56 IS ASSOCIATED WITH AN INCREASED RELAPSE INCIDENCE IN AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Madlen Jentzsch, 135314

NOVEL RARE VARIANTS IN EXON 4 OF GP6 HAVE LARGE EFFECTS ON GPVI EXPRESSION AND PLATELET FUNCTION

EHA Library, Suthesh Sivapalaratnam, 135319

A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF ELOTUZUMAB MONOTHERAPY IN PATIENTS WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA

EHA Library, Sundar Jagannath, 135309

LONG NON-CODING RNA PROFILING PROVIDES IMPORTANT PROGNOSTIC INFORMATION AND BIOLOGIC INSIGHTS IN YOUNGER PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (ALLIANCE/CALGB 8461, 9665, 20202)

EHA Library, Dimitrios PAPAIOANNOU, 135304

PRECLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF AG-519, AN ALLOSTERIC PYRUVATE KINASE-R ACTIVATOR

EHA Library, Hua Yang, 135324

HAPLOTRANSPLANTS VERSUS HLA-IDENTICAL DONOR (HID) FOR ALLOGENEIC STEM-CELL TRANSPLANTATION (ALLOSCT) IN REFRACTORY NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Haiwen Huang, 135284

AGONISTIC TARGETING OF TLR1/TLR2 FORCES ACUTE MYELOID LEUKEMIA CELLS INTO DIFFERENTIATION

EHA Library, Mia Eriksson, 135299

INTRODUCTION OF A PREOPERATIVE ANAEMIA CLINIC IMPROVES PERI-OPERATIVE TRANSFUSION USE

EHA Library, Ruzaika Cader, 135329

VERY LATE RELAPSE >5 YEARS AFTER FIRST DIAGNOSIS OF HODGKIN LYMPHOMA: AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP HD7-HD12 TRIALS

EHA Library, Paul J. Bröckelmann, 135289

FAST GENERATION OF CONDITIONAL ROSA26-BASED MOUSE MODELS THAT RECAPITULATE GENOMIC EVENTS IN HUMAN T-ALL

EHA Library, Tim Pieters, 135294

TRIGGERING THE TCR DEVELOPMENTAL CHECKPOINT ACTIVATES A THERAPEUTICALLY TARGETABLE TUMOR SUPPRESSIVE PATHWAY IN T-CELL LEUKEMIA

EHA Library, Amélie Trinquand, 135293

MULTICOHORT PHASE 2 STUDY OF PEMBROLIZUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL): KEYNOTE-087

EHA Library, Robert Chen, 135288

CHEMO-GENOMIC INTERROGATION OF PRIMARY ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS REVEALS RECURRENT CSF3R MUTATIONS AND SUBGROUP SENSITIVITY TO JAK INHIBITORS.

EHA Library, Vincent-Philippe Lavallée, 135298

SUBGROUP ANALYSES OF DIFFUSE LARGE B-CELL LYMPHOMA AND INDOLENT LYMPHOMA COHORTS FROM A PHASE IIA STUDY OF SINGLE-AGENT MOR208 IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA

EHA Library, Wojciech Jurczak, 135283

OUTCOME OF PATIENTS WITH REFRACTORY OR RELAPSED AML WITH IDH1 AND IDH2 MUTATIONS AFTER CONVENTIONAL SALVAGE THERAPY: A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)

EHA Library, Peter Paschka, 135303

THE USE OF PEGYLATED CARBOXYHEMOGLOBIN BOVINE IN PATIENTS FOR WHOM BLOOD IS NOT AN OPTION

EHA Library, Ronald Jubin, 135328

STAT3 GAIN-OF-FUNCTION MUTATIONS CAUSE AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME LIKE DISEASE BY DYSREGULATING EXPRESSION OF FAS AND BCL2 PROTEINS AND CAN BE THERAPEUTICALLY TARGETED BY BH3 MIMETICS

EHA Library, Ute Fischer, 135323

PHASE 1 STUDY OF VENETOCLAX MONOTHERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Shaji Kumar, 135308

IMPAIRED FUNCTION OF MESENCHYMAL STEM CELLS FROM IMMUNE THROMBOCYTOPENIA PATIENTS IN INDUCING REGULATORY DENDRITIC CELL DIFFERENTIATION VIA NOTCH2/JAGGED-1 SIGNALLING PATHWAY

EHA Library, Xiaohui Zhang, 135318

REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA: A PROSPECTIVE STUDY FROM THE UKALL14 TRIAL (ISRCTN 66541317)

EHA Library, Dina Okasha, 135313

TRANSCRIPTION-COUPLED GENETIC INSTABILITY MARKS ACUTE LYMPHOBLASTIC LEUKEMIA STRUCTURAL VARIATION HOTSPOTS

EHA Library, Merja Heinäniemi, 135292

TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA

EHA Library, Michael Kühn, 135297

CHECKMATE 205: A PHASE 2 STUDY OF NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN

EHA Library, Anas Younes, 135287

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF IMMUNOCOMPROMISED AND NON IMMUNOCOMPROMISED PLASMABLASTIC LYMPHOMA PATIENTS: ANALYSIS OF 135 PATIENTS TREATED IN THE LYSA GROUP

EHA Library, Emmanuelle Tchernonog, 135282

HIGHER DOSE DAUNORUBICIN APPEARS BENEFICIAL IN PATIENTS HARBOURING A FLT3-ITD MUTATION: UPDATED RESULTS OF THE UK NCRI AML17 TRIAL

EHA Library, Nigel Russell, 135302

RED CELL ALLOIMMUNISATION RISK IN PATIENTS WITH DIFFERENT TYPES OF INFECTIONS

EHA Library, Dorothea Evers, 135327

RICOLINOSTAT (ACY-1215), THE FIRST SELECTIVE HDAC6 INHIBITOR, COMBINED WITH POMALIDOMIDE AND DEXAMETHASONE SHOWS PROMISING EARLY PHASE 2 RESULTS IN RELAPSED-AND-REFRACTORY MULTIPLE MYELOMA: ACE-MM-102

EHA Library, Noopur Raje, 135307

MASITINIB FOR THE TREATMENT OF SEVERELY SYMPTOMATIC INDOLENT AND SMOLDERING SYSTEMIC MASTOCYTOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, INTERNATIONAL, PHASE 3 STUDY

EHA Library, Olivier Hermine, 135322

PLATELET PROPERTIES IN A PATIENT WITH STORMORKEN SYNDROME (STIM1 MUTATION) - ADHESION RECEPTOR LEVELS, CALCIUM HOMEOSTASIS AND PHOSPHATIDYLSERINE EXPOSURE

EHA Library, Katherine Cummins, 135317

PRETRANSPLANT ANTI-CCR4 ANTIBODY AGAINST ADULT T CELL LEUKEMIA/LYMPHOMA WAS ASSOCIATED WITH SIGNIFICANTLY INCREASED RISKS OF SEVERE/STEROID-REFRACTORY GVHD, NON-RELAPSE MORTALITY AND OVERALL MORTALITY

EHA Library, Shigeo Fuji, 135312

INVOLVEMENT OF THE TRANSCRIPTION FACTOR ASCL2 IN NORMAL AND LEUKEMIC HEMATOPOIESIS

EHA Library, Mallorie Dépond-Mangean, 133441

ENANTIOMER-SPECIFIC AND PARACRINE LEUKEMOGENICITY OF MUTANT IDH METABOLITE 2-HYDROXYGLUTARATE

EHA Library, Anuhar Chaturvedi, 133440

INTEGRATIVE ANALYSIS OF LINCRNA EXPRESSION IN 922 ACUTE MYELOID LEUKEMIA PATIENTS REVEALS MULTIPLE PROGNOSTIC GENE SIGNATURES

EHA Library, Dominik Beck, 133439

DIFFERENTIAL DNA METHYLATION IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA IS LINKED TO ALTERED GENE EXPRESSION OF ENHANCER TARGET GENES

EHA Library, Ying Qu, 133442

IN VIVO SHRNA SCREEN IDENTIFIES SPLICING FACTOR RBM25 AS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA

EHA Library, Ying Ge, 133443

NOTCH SIGNALLING INHIBITION AS A MULTI-TARGET THERAPY TO OVERCOME BONE MARROW MICROENVIRONMENT-MEDIATED DRUG RESISTANCE IN AML

EHA Library, Paul Takam Kamga, 133438

PHYSIOPATHOLOGICAL MECHANISM OF LEUKEMIC PREDISPOSITION IN ANKRD26-RD PATIENTS

EHA Library, Alessandro Donada, 133437

IN ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE CHROMOTHRIPSIS IS LINKED TO TP53 ALTERATION AND CELL CYCLE IMPAIRMENT

EHA Library, Frank Rücker, 133436

HIGH MTORC1 ACTIVITY DRIVES GLUCOSE METABOLISM ADDICTION AND SENSITIVITY TO G6PD INHIBITION IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Laury Poulain, 133444

ALVOCIDIB POTENTIATES THE ACTIVITY OF ABT-199 IN NONCLINICAL MODELS OF ACUTE MYELOID LEUKEMIA

EHA Library, Clifford Whatcott, 133445

POOR PROGNOSIS MONOSOMIC AND TRISOMIC ACUTE MYELOID LEUKEMIA ASSOCIATES WITH CHECKPOINTS AND CDC20 DEREGULATION: A NOVEL LEUKEMOGENIC MECHANISM AND THERAPEUTIC TARGETS

EHA Library, Giorgia Simonetti, 133435

CLONAL EVOLUTION IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Sibylle Cocciardi, 133434

WHOLE EXOME SEQUENCING REVEALS NOVEL CANDIDATE GENES IN FAMILIAL MDS/AML

EHA Library, Ana RIO-MACHIN, 133433

FIRST-IN-CLASS CDK7 INHIBITOR, INDUCES ROBUST APOPTOSIS IN ACUTE MYELOID LEUKEMIA AND DEMONSTRATES DURABLE IN VIVO EFFICACY

EHA Library, Yoon Jong Choi, 133446

IDENTIFICATION OF A NOVEL STAT5 INHIBITOR TO INTERFERE WITH THE ONCOGENIC ACTIVITIES OF STAT5 IN AML

EHA Library, Bettina Wingelhofer, 133447

SOMATIC DDX41 P.R525H MUTATION CAUSES GROWTH DEFECT IN HEMATOPOIETIC CELLS

EHA Library, Hirotaka Matsui, 133432

MOLECULAR CLASSIFICATION AND COMPARATIVE ANALYSIS OF ACUTE MYELOID LEUKEMIA MULTI-OMICS DATA USING THE INTERACTIVE HEMAP RESOURCE

EHA Library, Jake Lin, 133431

CLINICAL, HEMATOLOGICAL, BIOLOGIC AND MOLECULAR CHARACTERISTICS IN PATIENTS WHO DEVELOP ACUTE MYELOID LEUKEMIA FROM CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Klaus Geissler, 133430

PRELEUKEMIC CLONES IN NPM1-MUTATED AML MAY BE ASSOCIATED WITH EVOLUTION TO MYELODYSPLASTIC SYNDROME (MDS) OR MYELOPROLIFERATIVE NEOPLASM (MPN)

EHA Library, Sarah Morin, 133429

PROTEIN PHOSPHATASE 4 REGULATORY SUBUNIT 2 (PPP4R2) IS RECURRENTLY DELETED IN ACUTE MYELOID LEUKEMIA (AML) AND REQUIRED FOR EFFICIENT DNA DOUBLE STRAND BREAK REPAIR

EHA Library, Julia K. Herzig, 133428

LACK OF PROGNOSTIC SIGNIFICANCE OF CD20 EXPRESSION IN ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE, B-CELL PRECURSOR ALL TREATED ACCORDING TO MRD-ORIENTED PROTOCOLS

EHA Library, Josep-Maria Ribera, 133427

DELETIONS OF IKZF1 GENE, BUT NOT GENETIC RISK GROUPS, DEFINED BY COPY-NUMBER ALTERATIONS, ARE PROGNOSTICALLY SIGNIFICANT FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA ON ALL-MB 2008 PROTOCOL

EHA Library, Grigory Tsaur, 133426

PATIENT-REPORTED OUTCOMES FROM A GLOBAL PHASE 3 RANDOMIZED CONTROLLED TRIAL OF INOTUZUMAB OZOGAMICIN VERSUS STANDARD CARE FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, H Kantarjian, 133425

TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sofie Peirs, 133424

TARGETED LOCUS AMPLIFICATION & NEXT GENERATION SEQUENCING FOR THE DETECTION OF RECURRENT AND NOVEL GENE FUSIONS FOR IMPROVED TREATMENT DECISIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Monique den Boer, 133423

NBN GENE VARIABILITY IS ASSOCIATED WITH INCREASED RISK OF CNS RELAPSE AMONG CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Bartlomiej Tomasik, 133422

MUTATIONS IN TP53 AND JAK2 GENES ARE ASSOCIATED WITH POOR PROGNOSIS IN PEDIATRIC AND ADULT PATIENTS WITH B-CELL PRECURSOR ALL

EHA Library, Jesús M Hernández-Rivas, 133421

MIR-126 DRIVEN LEUKEMIA: A MURINE MODEL TO UNDERSTAND HUMAN B-ALL PATHOGENESIS

EHA Library, Matteo Maria Naldini, 133420

CAPTURE-BASED NEXT GENERATION SEQUENCING (NGS) IDENTIFIES ALSO RARE IG/TCR REARRANGEMENTS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Orietta Spinelli, 133419

THE ROLE OF CNOT3 AND THE ENTIRE CCR4-NOT COMPLEX IN TUMOR DEVELOPMENT

EHA Library, Carmen Vicente, 133418

INSIGHTS INTO THE MOLECULAR EVOLUTION OF BCR-ABLP190 MEDIATED PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Franziska Auer, 133417

THE HISTONE DEACETYLASE INHIBITOR GIVINOSTAT (ITF2357) HAS A POTENT ANTI-TUMOR ACTIVITY AGAINST CRLF2 REARRANGED LEUKEMIA

EHA Library, Giovanni Cazzaniga, 133416

UNFAVORABLE PROGNOSTIC VALUE OF BCR-ABL1-LIKE IS INDEPENDENT OF AN INTEGRATED GENETIC RISK SCORE IN PEDIATRIC BCP-ALL

EHA Library, Judith Boer, 133415

IN VIVO ROLE OF ACTIVATION INDUCED CYTIDINE DEAMINASE (AID) EXPRESSION IN THE DEVELOPMENT OF PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Franziska Auer, 133414